To ask Her Majesty's Government what assessment they have made of the public health benefits of adopting the recommendation made by the Joint Committee on Vaccination and Immunisation at its meeting in October 2017 that the pneumococcal immunisation programme move to a 1 plus 1 schedule.
In October 2017, the JCVI considered all relevant evidence on the pneumococcal conjugate vaccine (PCV) and reviewed modelling undertaken by Public Health England on the impact of a reduced-dose PCV schedule in the United Kingdom. The JCVI advised a revised schedule for PCV with two doses of vaccine offered (a “1+1” schedule) rather than three. The JCVI is currently consulting on and reviewing its advice and will agree its final advice at a future Committee meeting, which will take into account public health arguments. The Department will consider and respond to this final advice in due course.